- Home
- RXST vs BBNX Comparison
RXST vs BBNX Comparison
Compare RXST & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXST
- BBNX
- Stock Information
- Founded
- RXST 1997
- BBNX 2015
- Country
- RXST United States
- BBNX United States
- Employees
- RXST N/A
- BBNX N/A
- Industry
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BBNX Medical/Dental Instruments
- Sector
- RXST Health Care
- BBNX Health Care
- Exchange
- RXST Nasdaq
- BBNX Nasdaq
- Market Cap
- RXST 553.1M
- BBNX 649.9M
- IPO Year
- RXST 2021
- BBNX 2025
- Fundamental
- Price
- RXST $8.03
- BBNX $12.67
- Analyst Decision
- RXST Hold
- BBNX Strong Buy
- Analyst Count
- RXST 11
- BBNX 10
- Target Price
- RXST $19.40
- BBNX $25.20
- AVG Volume (30 Days)
- RXST 1.7M
- BBNX 467.2K
- Earning Date
- RXST 08-07-2025
- BBNX 07-29-2025
- Dividend Yield
- RXST N/A
- BBNX N/A
- EPS Growth
- RXST N/A
- BBNX N/A
- EPS
- RXST N/A
- BBNX N/A
- Revenue
- RXST $148,310,000.00
- BBNX $69,830,000.00
- Revenue This Year
- RXST $22.16
- BBNX $32.79
- Revenue Next Year
- RXST $20.91
- BBNX $36.59
- P/E Ratio
- RXST N/A
- BBNX N/A
- Revenue Growth
- RXST 46.70
- BBNX 38911.17
- 52 Week Low
- RXST $6.32
- BBNX $8.89
- 52 Week High
- RXST $58.23
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- RXST 21.66
- BBNX N/A
- Support Level
- RXST $6.32
- BBNX N/A
- Resistance Level
- RXST $8.50
- BBNX N/A
- Average True Range (ATR)
- RXST 0.77
- BBNX 0.00
- MACD
- RXST -0.52
- BBNX 0.00
- Stochastic Oscillator
- RXST 21.50
- BBNX 0.00
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.